Pascal Deschatelets
Founder en APELLIS PHARMACEUTICALS, INC. .
Fortuna: 66 M $ al 31/03/2024
Perfil
Pascal Deschatelets es un empresario que fundó Apellis Pharmaceuticals, Inc, Potentia Pharmaceuticals, Inc, Revon Systems, Inc y Syntetica Fine Chemicals. En la actualidad, ocupa el cargo de Director Científico de Apellis Pharmaceuticals, Inc. También forma parte del consejo de administración de Revon Systems, Inc. Pascal Deschatelets ocupó anteriormente el cargo de Director de Operaciones de Potentia Pharmaceuticals, Inc. Se doctoró en la Universidad de Montreal.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 08/04/2024 | 1 115 983 ( 0.93% ) | 66 M $ | 31/03/2024 |
Cargos activos de Pascal Deschatelets
| Empresas | Cargo | Inicio |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Founder | 25/09/2009 |
Revon Systems, Inc.
 Revon Systems, Inc. Packaged SoftwareTechnology Services Revon Systems, Inc. operates a platform that connects physicians and patients for medicine. Its products include Revon Patient App, Revon Physician App, Alexa Skill and Research Coordinators Portal. The firm's platform’s digital interface supports data collection for the investigation of the performance of pharmaceutical and other interventions in various patient populations. It enables digital registry services, real world evidence collection and patient reported outcomes tracking for pharmaceutical and medical device companies conducting clinical trials. The company was founded by Cedric Francois and Pascal Deschatelets and is headquartered in Crestwood, KY. | Founder | - |
Antiguos cargos conocidos de Pascal Deschatelets.
| Empresas | Cargo | Fin |
|---|---|---|
Potentia Pharmaceuticals, Inc.
 Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Founder | 01/09/2016 |
| Syntetica Fine Chemicals | Founder | - |
Formación de Pascal Deschatelets.
| University of Montréal | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| APELLIS PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Potentia Pharmaceuticals, Inc.
Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Health Technology |
Revon Systems, Inc.
Revon Systems, Inc. Packaged SoftwareTechnology Services Revon Systems, Inc. operates a platform that connects physicians and patients for medicine. Its products include Revon Patient App, Revon Physician App, Alexa Skill and Research Coordinators Portal. The firm's platform’s digital interface supports data collection for the investigation of the performance of pharmaceutical and other interventions in various patient populations. It enables digital registry services, real world evidence collection and patient reported outcomes tracking for pharmaceutical and medical device companies conducting clinical trials. The company was founded by Cedric Francois and Pascal Deschatelets and is headquartered in Crestwood, KY. | Technology Services |
| Syntetica Fine Chemicals |
- Bolsa de valores
- Insiders
- Pascal Deschatelets
